Brixton Bio

activeseries-b
series-b
Stage
2
Investors

About

Brixton Bio is a clinical-stage life sciences company focused on developing novel, drug-free therapies for chronic and acute pain, including its leading product Neural Ice™, an injectable technology designed to provide long-lasting pain relief.

Explore Brixton Bio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.